000			01334 a2200397 4500
005			20250516064302.0
264		0	_c20120404
008			201204s 0 0 fre d
022			_a2214-8116
024	7		_a10.1016/j.jmv.2011.10.001 _2doi
040			_aNLM _beng _cNLM
100	1		_aMairesse, S
245	0	0	_a[Focus on beta-blockers for vascular specialists in 2012]. _h[electronic resource]
260			_bJournal des maladies vasculaires _cDec 2011
300			_a339-47 p. _bdigital
500			_aPublication Type: Journal Article; Review
650	0	4	_aAdrenergic beta-Antagonists _xadverse effects
650	0	4	_aAged
650	0	4	_aAtrial Fibrillation _xdrug therapy
650	0	4	_aCardiovascular Diseases _xdrug therapy
650	0	4	_aContraindications
650	0	4	_aCoronary Disease _xdrug therapy
650	0	4	_aFemale
650	0	4	_aHeart Failure
650	0	4	_aHumans
650	0	4	_aHypertension _xdrug therapy
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aPerioperative Period
650	0	4	_aRisk Factors
650	0	4	_aVentricular Dysfunction, Left _xdrug therapy
700	1		_aBlacher, J
700	1		_aSafar, M-E
773	0		_tJournal des maladies vasculaires _gvol. 36 _gno. 6 _gp. 339-47
856	4	0	_uhttps://doi.org/10.1016/j.jmv.2011.10.001 _zAvailable from publisher's website
999			_c21321353 _d21321353